Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 4, 2012 - Issue
Submit an article Journal homepage
122
Views
4
CrossRef citations to date
0
Altmetric
Review

Economic evaluation of bevacizumab in the treatment of non-small cell lung cancer (NSCLC)

Chun-Ru Chien1 Department of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan;2 School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan
&
Ya-Chen Tina Shih3 Section of Hospital Medicine, Department of Medicine, University of Chicago, Chicago, IL, USACorrespondence[email protected]
Pages 201-208 | Published online: 25 Jul 2012

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Christos Chouaïd, Perinne Crequit, Isabelle Borget & Alain Vergnenegre. (2015) Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic review. ClinicoEconomics and Outcomes Research 7, pages 9-15.
Read now
A Vergnenègre, I Borget & C Chouaid. (2013) Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents. ClinicoEconomics and Outcomes Research 5, pages 137-141.
Read now
Alain Vergnenegre, Isabelle Borget & Christos Chouaid. (2013) Treatment of lung cancer: will financial issues become a criterion of choice?. Expert Review of Pharmacoeconomics & Outcomes Research 13:3, pages 273-275.
Read now

Articles from other publishers (1)

Anna K. Nowak, Solenn Brosseau, Alistair Cook & Gérard Zalcman. (2020) Antiangiogeneic Strategies in Mesothelioma. Frontiers in Oncology 10.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.